USFDA APPLICATION NUMBER - 20164 / DOSAGE - INJECTABLE;SUBCUTANEOUS - 150MG/ML (150MG/ML)
Active Ingredient/Active Moiety | ||
Ingredient Name | Basis of Strength | Strength |
---|---|---|
enoxaparin sodium(UNII: 8NZ41MIK1O) (enoxaparin - UNII:E47C0NF7LV) | enoxaparin sodium | 150mg in 1 | 120mg in 0.8 | 300mg in 3 | 100mg in 1 | 80mg in 0.8 | 60mg in 0.6 | 40mg in 0.4 | 30mg in 0.3 |
Inactive Ingredients
Ingredient Name | Fresenius Kabi USA, LLC | Sandoz Inc | sanofi-aventis U.S. LLC | Actavis Pharma, Inc. | Asclemed USA, Inc. | BE Pharmaceuticals Inc. | Cardinal Health | Gland Pharma Limited | Teva Parenteral Medicines, Inc. | Zydus Pharmaceuticals USA Inc. |
---|---|---|---|---|---|---|---|---|---|---|
benzyl alcohol(LKG8494WBH) | ||||||||||
WATER(059QF0KO0R) |
LOOKING FOR A SUPPLIER?